311 related articles for article (PubMed ID: 19252335)
21. Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation.
Liu Z; Liu K
Curr Drug Metab; 2016; 17(5):456-68. PubMed ID: 26750112
[TBL] [Abstract][Full Text] [Related]
22. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
Mao Q; Lai Y; Wang J
Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
[TBL] [Abstract][Full Text] [Related]
23. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.
Marquez B; Van Bambeke F
Curr Drug Targets; 2011 May; 12(5):600-20. PubMed ID: 21039335
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.
Yamazaki M; Suzuki H; Sugiyama Y
Pharm Res; 1996 Apr; 13(4):497-513. PubMed ID: 8710738
[TBL] [Abstract][Full Text] [Related]
26. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
Chaves C; Remiao F; Cisternino S; Decleves X
Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
[TBL] [Abstract][Full Text] [Related]
27. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
[TBL] [Abstract][Full Text] [Related]
28. Transporter-Mediated Drug-Drug Interactions and Their Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167
[TBL] [Abstract][Full Text] [Related]
29. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
30. The role of hepatic transporters in drug elimination.
Funk C
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
[TBL] [Abstract][Full Text] [Related]
31. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.
Yu XQ; Xue CC; Wang G; Zhou SF
Curr Drug Metab; 2007 Dec; 8(8):787-802. PubMed ID: 18220559
[TBL] [Abstract][Full Text] [Related]
33. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
Fallon JK; Smith PC; Xia CQ; Kim MS
Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
[TBL] [Abstract][Full Text] [Related]
34. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
Döring B; Petzinger E
Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
36. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
El-Kattan AF; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
[TBL] [Abstract][Full Text] [Related]
37. Protein-protein interactions of drug uptake transporters that are important for liver and kidney.
Zhang Y; Hagenbuch B
Biochem Pharmacol; 2019 Oct; 168():384-391. PubMed ID: 31381872
[TBL] [Abstract][Full Text] [Related]
38. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
39. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
Smith NF; Figg WD; Sparreboom A
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
[TBL] [Abstract][Full Text] [Related]
40. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
Yang X; Han L
Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
